Genetic susceptibility variants associated with colorectal cancer prognosis

Carcinogenesis

Volumn 34, Issue 10, 2013, Pages 2286-2291

  Abulí, Anna ^a,b   Lozano, Juan José ^c   Rodríguez Soler, María ^d   Jover, Rodrigo ^d   Bessa, Xavier ^b   Muñoz, Jenifer ^a   Esteban Jurado, Clara ^a   Fernández Rozadilla, Ceres ^e   Carracedo, Angel ^e   Ruiz Ponte, Clara ^e   Cubiella, Joaquín ^f   Balaguer, Fran esc ^a   Bujanda, Luis ^g   Reñé, Josep M ^h   Clofent, Juan ⁱ   Morillas, Juan Diego ^j   Nicolás Pérez, David ^k   Xicola, Rosa M ^l   Llor, Xavier ^l   Piqué, Josep M ^a   Andreu, Montserrat ^b   Castells, Antoni ^a   Castellví Bel, Sergi ^a   more..

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^e UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^f Complexo Hospitalario de Ourense ^*  (Spain)

^g UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^h HOSPITAL ARNAU DE VILANOVA   (Spain)

ⁱ HOSPITAL DO MEIXOEIRO   (Spain)

^j HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^k HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^l UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ALLELE; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; COLORECTAL CANCER; DISEASE FREE SURVIVAL; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION SURVEILLANCE; PROGNOSIS;

EID: 84885123097     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt179     Document Type: Article

References (22)

1. Ferlay, J. et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 127, 2893-2917.
2. Chang, G.J. et al. (2009) Practical application of a calculator for conditional survival in colon cancer. J. Clin. Oncol., 27, 5938-5943.
3. Edge, S.B. et al. (eds) (2010) AJCC Cancer Staging Manual. 7th edn. Springer, New York, NY.
4. Dray, X. et al. (2003) Influence of dietary factors on colorectal cancer survival. Gut, 52, 868-873.
5. Haydon, A.M. et al. (2006) Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut, 55, 62-67.
6. Hong, S.P. et al. (2012) The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer. Eur. J. Cancer, 48, 1235-1243.
7. Kalady, M.F. et al. (2012) BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis. Dis. Colon Rectum, 55, 128-133.
8. Lindström, L.S. et al. (2007) Familial concordance in cancer survival: a Swedish population-based study. Lancet Oncol., 8, 1001-1006.
9. Koessler, T. et al. (2009) Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer. Int. J. Cancer, 124, 1887-1891.
10. Lin, M. et al. (2012) Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients. Clin. Cancer Res., 18, 3982-3991.
11. Slattery, M.L. et al. (2012) Toll-like receptor genes and their association with colon and rectal cancer development and prognosis. Int. J. Cancer, 130, 2974-2980.
12. Tenesa, A. et al. (2009) New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat. Rev. Genet., 10, 353-358.
13. Houlston, R.S. et al. (2010) Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat. Genet., 42, 973-977.
14. Tomlinson, I.P. et al. (2011) Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet., 7, e1002105.
15. Dunlop, M.G. et al. (2012) Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk. Nat. Genet., 44, 770-776.
16. Kinnersley, B. et al. (2012) The TERT variant rs2736100 is associated with colorectal cancer risk. Br. J. Cancer, 107, 1001-1008.
17. Tenesa, A. et al. (2010) Ten common genetic variants associated with colorectal cancer risk are not associated with survival after diagnosis. Clin. Cancer Res., 16, 3754-3759.
18. Xing, J. et al. (2011) GWAS-identified colorectal cancer susceptibility locus associates with disease prognosis. Eur. J. Cancer, 47, 1699-1707.
19. Phipps, A.I. et al. (2012) Association between colorectal cancer susceptibility loci and survival time after diagnosis with colorectal cancer. Gastroenterology, 143, 51-4.e4.
20. Piñol, V. et al. (2005) Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA, 293, 1986-1994.
21. Fernández-Rozadilla, C. et al. (2010) Colorectal cancer susceptibility quantitative trait loci in mice as a novel approach to detect low-penetrance variants in humans: a two-stage case-control study. Cancer Epidemiol. Biomarkers Prev., 19, 619-623.
22. Peña, C. et al. (2005) E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum. Mol. Genet., 14, 3361-3370.